Found vs Lavender Sky Health vs Mochi Health (2026)

On tirzepatide, the order is Mochi Health↗ ($278) → Found ($289) → Lavender Sky Health↗ ($352) — gaps of $11 and then $63 a month, a $888 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

§ Each record, condensed

The three records, one screen

Mochi Health: the record, condensed

On tirzepatide, the number that matters at Mochi Health is $278 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

Inside that $278 sits a mandatory $79-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $199, and it is not a price anyone can actually pay, because the membership cannot be declined.

To place the number: #4 of 17 verified programs, with the floor $63/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $171 a month. A year at this figure: $3,336 monthly-billed.

Start with the load-bearing figure: $178 a month, all-in, is what Mochi Health charges for semaglutide at the 2.4 mg basis. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

The all-in figure already contains a compulsory $79 monthly membership. That is the honest way to quote it: a bundled price is only misleading when its parts are advertised separately, and here the medication-only $99 would be exactly that kind of mirage.

Context for that figure: it ranks #8 of 20 in the verified semaglutide index — $45/month above the floor (Oak Longevity, $133) — and sits $171 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,136.

Operationally at Mochi Health: shipping included; commitment membership recurs monthly; cancellation cancel membership any time; recurs until cancelled; pharmacy named (company-owned compounding facility); states: most states; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Mochi Health page · visit Mochi Health ↗

Found: the record, condensed

On tirzepatide, the number that matters at Found is $289 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Found is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

There is no membership line. $289 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #6 of 17 in the verified tirzepatide index — $74/month above the floor (NexLife, $215) — and sits $160 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $3,468.

Found’s semaglutide program bills $289 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #15 of 20 verified programs, with the floor $156/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $60 a month. A year at this figure: $3,468 monthly-billed.

Operationally at Found: shipping included; commitment none month-to-month; prepaid terms for lowest rate; cancellation membership recurs; prepaid terms are paid up front; pharmacy not publicly named — ask in writing before paying; states: most states; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Found page · visit Found ↗

Lavender Sky Health: the record, condensed

On tirzepatide, the number that matters at Lavender Sky Health is $352 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The structure is tiered: the advertised entry point is $200, but the maintenance figure — the one a full year is actually billed at — is $352. That $152 gap between the ad and the anniversary is the single most important line in this record.

Inside that $352 sits a mandatory $25-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $327, and it is not a price anyone can actually pay, because the membership cannot be declined.

Context for that figure: it ranks #12 of 17 in the verified tirzepatide index — $137/month above the floor (NexLife, $215) — and sits $97 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $4,224.

Start with the load-bearing figure: $174 a month, all-in, is what Lavender Sky Health charges for semaglutide at the 2.4 mg basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.

Inside that $174 sits a mandatory $25-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $149, and it is not a price anyone can actually pay, because the membership cannot be declined.

To place the number: #6 of 20 verified programs, with the floor $41/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $175 a month. A year at this figure: $2,088 monthly-billed.

Operationally at Lavender Sky Health: shipping included; commitment monthly plan fee recurs; cancellation plan fee recurs until cancelled; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Lavender Sky Health page · visit Lavender Sky Health ↗

§ The three-way read

Prices, gaps, and what sits inside them

Mochi Health holds the low ground at $278 — dose-flat, so that figure is a ceiling (its $79 membership already inside). Found follows at $289 (+$11/mo, $132/yr). Lavender Sky Health tops the trio at $352 (+$74/mo over the leader, $888/yr) — note its record’s watch-out below.

The semaglutide picture reshuffles the order: Lavender Sky Health $174 → Mochi Health $178 → Found $289 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.

§ Category winners among the three

Who wins what

Cheapest month-to-month: Mochi Health ($278); cheapest 12-month path: Mochi Health ($3,336); simplest billing (no membership): Found; dose-flat structure: Mochi Health and Found; named-pharmacy transparency: Mochi Health; cheapest semaglutide of the three: Lavender Sky Health ($174).

Every winner above is a computation, not a placement; the pairwise pages carry the full duels: Mochi Health vs Found · Mochi Health vs Lavender Sky Health (record · record) · Found vs Lavender Sky Health (record · record).

§ Structure, three ways

Everything besides the three prices

Memberships: Mochi Health $79/mo (inside its figure); Found none; Lavender Sky Health $25/mo (inside its figure). Structures: Mochi Health dose-flat; Found dose-flat; Lavender Sky Health step/tiered. Pharmacies: Mochi Health named (company-owned compounding facility); Found not named; Lavender Sky Health not named. States: Mochi Health — most states; Found — most states; Lavender Sky Health — not published. Exit terms: Mochi Health — cancel membership any time; recurs until cancelled; Found — membership recurs; prepaid terms are paid up front; Lavender Sky Health — plan fee recurs until cancelled.

The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: Mochi Health source-verified (2026-08-05); Found third-party reported (2026-08-05); Lavender Sky Health source-verified (2026-08-05).

The trio on semaglutide, across time

3 mo: Lavender Sky Health $522 vs Mochi Health $534 vs Found $867 6 mo: Lavender Sky Health $1,044 vs Mochi Health $1,068 vs Found $1,734 12 mo: Lavender Sky Health $2,088 vs Mochi Health $2,136 vs Found $3,468 — monthly-billed totals; prepaid paths where published appear on each provider page.

§ Twelve and twenty-four months

The trio, annualized

Mochi Health: $3,336/yr monthly-billed; Found: $3,468/yr monthly-billed; Lavender Sky Health: $4,224/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $1,776 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.

The elimination read

Work it as eliminations rather than a beauty contest. Lavender Sky Health enters owing an explanation: $74/month above Mochi Health compounds to $888 a year — real therapy-months of money — so its record has to name what the premium buys ($25/mo of bundled membership services) or it exits first. Found survives the first cut only to face the harder question — whether nothing structural — its case is purely situational is worth $11 a month to you — because a middle option that cannot answer it is just the expensive option with better camouflage. Mochi Health is what remains: the arithmetic answer at $278, dethroned only by a state gap, a structural need, or a prescriber’s judgment — the three things this page deliberately cannot decide.

The same trio on best published rate: Mochi Health $278 → Found $289 → Lavender Sky Health $352 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — Mochi Health $834, Found $867, Lavender Sky Health $1,056; 6 months — Mochi Health $1,668, Found $1,734, Lavender Sky Health $2,112. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.

Grade the three records before trusting the three prices. On the five-point disclosure checklist (price, pharmacy, states, cancellation, source-verification): Mochi Health 5/5 · Found 3/5 · Lavender Sky Health 4/5. The gap between Mochi Health (5/5) and Found (3/5) is itself information: undisclosed axes are where the questions in each provider’s review earn their keep. The concrete splits — pharmacy named: Mochi Health yes, Found and Lavender Sky Health no — convert directly into pre-purchase emails. Every score is a computation from the dataset, contestable at the corrections desk like any other figure.

The three-way verdict compresses cleanly: Mochi Health is the default on arithmetic; Found earns the middle only where its structure (flat pricing) solves something the floor does not; and Lavender Sky Health’s $74/month premium over the leader — $888 a year, roughly 3.2 extra months of therapy at the floor rate — needs a named justification from its record, not a vibe. Insurance coverage, where it exists, outranks all three.